Eckert & Ziegler Strahlen- und Medizintechnik Forecast, price target & analysts
Why the stock moved Beta
Eckert & Ziegler Strahlen- und Medizintechnik Target price 2025 - Analyst rating & recommendation
Eckert & Ziegler Strahlen- und Medizintechnik Classifications & Recommendation:
Eckert & Ziegler Strahlen- und Medizintechnik Price Target
| Target Price | €22.13 |
| Price | €16.27 |
| Potential |
36.04%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Eckert & Ziegler Strahlen- und Medizintechnik 2026 .
The average Eckert & Ziegler Strahlen- und Medizintechnik target price is €22.13.
This is
36.04%
register free of charge
€25.20
54.89%
register free of charge
€21.92
34.71%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend Eckert & Ziegler Strahlen- und Medizintechnik to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Eckert & Ziegler Strahlen- und Medizintechnik stock has an average upside potential 2026 of
36.04%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million € | 295.85 | 321.31 |
| 20.22% | 8.61% | |
| EBITDA Margin | 23.73% | 29.23% |
| 18.13% | 23.17% | |
| Net Margin | 11.25% | 15.69% |
| 5.26% | 39.48% |
4 Analysts have issued a sales forecast Eckert & Ziegler Strahlen- und Medizintechnik 2025 . The average Eckert & Ziegler Strahlen- und Medizintechnik sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Eckert & Ziegler Strahlen- und Medizintechnik EBITDA forecast 2025. The average Eckert & Ziegler Strahlen- und Medizintechnik EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Eckert & Ziegler Strahlen- und Medizintechnik Analysts have issued a net profit forecast 2025. The average Eckert & Ziegler Strahlen- und Medizintechnik net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | 0.53 | 0.81 |
| 26.19% | 52.83% | |
| P/E | 20.19 | |
| EV/Sales | 3.08 |
4 Analysts have issued a Eckert & Ziegler Strahlen- und Medizintechnik forecast for earnings per share. The average Eckert & Ziegler Strahlen- und Medizintechnik EPS is
This results in the following potential growth metrics and future valuations:
Eckert & Ziegler Strahlen- und Medizintechnik...
Current Eckert & Ziegler Strahlen- und Medizintechnik Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Locked
➜
Locked
|
Locked | Sep 11 2025 |
| HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
| HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
| HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | Dec 02 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG:
Locked
➜
Locked
|
Sep 11 2025 |
|
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
Aug 11 2025 |
|
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
Apr 01 2025 |
|
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
Dec 02 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
